Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
9
×
life sciences
9
×
national blog main
clinical trials
boston
national top stories
fda
deals
medical device
national
new york blog main
new york top stories
novartis
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
startups
abbvie
amgen
arvinas
bayer
biotech ipos
boulder/denver blog main
boulder/denver top stories
cancer diagnostics
detroit blog main
detroit top stories
indiana blog main
indiana top stories
investing
ipo
merck
multiple myeloma
new york
non-hodgkin lymphoma
What
company
9
×
ipo
drug
medicines
million
developing
new
raised
raises
bio
biotech
brings
firms
genetic
life
public
science
tests
therapeutics
way
acquire
acquisitions
agreed
aiming
albert
analysis
bacteria
biggest
billion
biology
biotechs
bioworks
blood
bourla
bring
broader
called
cancer
cash
ceo
Language
unset
unknown
Current search:
company
×
" life sciences "
×
" boston top stories "
×
@xconomy.com
3 years ago
Dyne’s Upsized IPO Brings In $233M for Muscle Disorders Drug R&D
@xconomy.com
3 years ago
Grail Files to Go Public; 5 More Life Science Firms Join the IPO Queue
@xconomy.com
3 years ago
Goldfinch Raises $100M for Kidney Drug Studies Now, Perhaps an IPO Later
@xconomy.com
4 years ago
Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
4 years ago
Synlogic Lands $80M from Ginkgo to Ramp Up “Living Medicines” R&D
@xconomy.com
5 years ago
Six Life Science Firms Close Q3 with an IPO, More Are on the Way
@xconomy.com
5 years ago
Renovia Raises $42M to Back Digital Treatment for Incontinence